Production of human granulocyte colony stimulating factor by various kinds of stromal cells in vitro detected by enzyme immunoassay and in situ hybridization

Stem Cells
K WatariS Nagata

Abstract

Production of human granulocyte colony stimulating factor (G-CSF) by stromal cells was studied in vitro. Induction of G-CSF by interleukin 1 (IL-1) and lipopolysaccharide (LPS) was compared using enzyme immunoassay in various kinds of stromal cells. Primary human bone marrow stromal cells, a human bone marrow-derived stromal cell line (KM-102), and peripheral blood monocytes secreted small amounts of G-CSF without stimulation, while vascular endothelial cells and skin fibroblasts secreted G-CSF only when induced by IL-1 or LPS. The production of G-CSF by monocytes was stimulated predominantly by LPS, whereas that by KM-102 cells, endothelial cells, and fibroblasts was induced by IL-1 but much less so by LPS. IL-1 and LPS stimulated similar levels of G-CSF production by primary bone marrow stromal cells which consisted of various types of cells. In situ hybridization for G-CSF mRNA showed that only a small proportion of primary bone marrow stromal cells expressed a large amount of G-CSF mRNA upon stimulation. The positive cells were round or oval in shape, while most of the spindle-shaped stromal cells were negative for specific grains. Although further characterization of positive cells is needed, the results suggest that bone ...Continue Reading

References

Jan 1, 1991·The American Journal of Pediatric Hematology/oncology·S Asano
Mar 31, 1989·Journal of Immunological Methods·H MotojimaM Fukushima
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M E HarperF Wong-Staal
Apr 1, 1986·Cryobiology·T TakahashiR J Williams
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K Harigaya, H Handa

❮ Previous
Next ❯

Citations

Nov 17, 1999·Scandinavian Journal of Immunology·M HannenD Körholz
Jun 10, 2014·PloS One·Bonggi LeeJianhua Shao
Jan 1, 2016·The American Journal of Pathology·Gabrielle L GoldbergIan P Wicks
Aug 21, 2012·Annals of the New York Academy of Sciences·Stefanie BuglHans-Georg Kopp
Nov 18, 2006·Journal of Molecular and Cellular Cardiology·Jason C KovacicRobert M Graham
Nov 27, 2010·The Lancet Infectious Diseases·Sarah K Browne, Steven M Holland
Jan 13, 2012·The Journal of Clinical Endocrinology and Metabolism·D GonzalezR S Conlan
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jeong-Ho KimMarc Montminy
May 24, 2019·In Vitro Cellular & Developmental Biology. Animal·Yu ShimizuAkimasa Fukui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.